September 23, 2020 THE U.S. FOOD AND DRUG ADMINISTRATION (“FDA”) AGAIN SUPPLEMENTS ITS MARCH 18 GUIDANCE ENTITLED “CONDUCT OF CLINICAL TRIALS OF MEDICAL PRODUCTS DURING COVID-19 PUBLIC HEALTH EMERGENCY” The… Read more »
September 14, 2020 On Friday, September 11, 2020, the U.S. Department of Labor’s Wage and Hour Division (DOL) announced revisions to the regulations that govern paid sick leave and expanded… Read more »
Virginia will elect a new Governor, Lt. Governor and Attorney General on November 2, 2021. Candidates are lining. Please see an updated list of candidates below: ************************************************************************************* GOVERNOR: Republican: Amanda… Read more »
August 19, 2020 On August 17, 2020, CMS issued revised guidance (QSO-20-35-ALL) for survey activities and enforcement actions for long-term care facilities, non-long-term care facilities, and laboratories. The memorandum updates… Read more »
August 6, 2020 The Office of Management and Budget renewedthe Centers for Medicare and Medicaid Services’ (CMS) instructions and Advance Notice of Noncoverage (ABN), Form CMS-R-131, which is distributed by… Read more »
July 24, 2020 The Centers for Medicare and Medicaid Services (“CMS”) announced that it plans to resume pre-payment and post-payment medical review activity on August 3, 2020, regardless of the… Read more »
July 23, 2020 On Friday, June 12, the Virginia Department of Labor and Industry (DOLI) published a draft emergency temporary standard (ETS), 16 VAC 25-220, that applies to all employers… Read more »
June 10, 2020 On June 1, 2020, the US Department of Justice (“DOJ”) issued updated guidance on the “Evaluation of Corporate Compliance Programs” (2020 Guidance) designed to assist prosecutors on… Read more »
July 7, 2020 Please see a list of current declared and potential candidates for Governor, Lt. Governor and Attorney General in Virginia. The election will take place on November 2,… Read more »
July 7, 2020 THE U.S. FOOD AND DRUG ADMINISTRATION (“FDA”) AGAIN SUPPLEMENTS ITS MARCH 18 GUIDANCE ENTITLED “CONDUCT OF CLINICAL TRIALS OF MEDICAL PRODUCTS DURING COVID‑19 PUBLIC HEALTH EMERGENCY” The… Read more »
